Incannex Healthcare Form 4: 11,302,608-share grant to director
Rhea-AI Filing Summary
Incannex Healthcare (IXHL) director Troy Valentine reported acquiring 11,302,608 shares of common stock at $0 on November 14, 2025, as a restricted stock grant under the company’s 2023 Equity Incentive Plan. Following the grant, he beneficially owned 12,001,858 shares directly.
The restricted shares vest in four tranches of 2,825,652 each on December 10, 2025; June 30, 2026; June 30, 2026; and June 30, 2027. He also reported indirect holdings, including 242,862 shares via Alignment Capital Pty Ltd.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 11,302,608 shares
Net Buy
6 txns
Insider
Valentine Troy
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, $0.0001 par value per share | 11,302,608 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock, $0.0001 par value per share — 12,001,858 shares (Direct);
Common Stock — 10,000 shares (Indirect, By Mr. Valentine as the beneficiary of the GFCR Investments Trust);
Common Stock — 30,000 shares (Indirect, By Valplan Pty Ltd, a company of which Mr. Valentine is a director);
Common Stock — 10,000 shares (Indirect, By Tranaj Nominees Pty Ltd, a company of which Mr. Valentine is a director);
Common Stock — 242,862 shares (Indirect, By Alignment Capital Pty Ltd, a company of which Mr. Valentine is a director and major shareholder);
Common Stock — 44,400 shares (Indirect, By Cityside Pty Ltd, a company wholly-owned by Mr. Valentine)
Footnotes (1)
- F1. Includes the following shares of restricted stock (the "Shares") granted on November 14, 2025, under the Issuer's 2023 Equity Incentive Plan, (i) 2,825,652 Shares that vest in full on December 10, 2025, (ii) 2,825,652 Shares that vest in full on June 30, 2026, (iii) 2,825,652 Shares that vest in full on June 30, 2026 and (iv) 2,825,652 Shares that vest in full on June 30, 2027.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did IXHL disclose in this Form 4?
Director Troy Valentine reported acquiring 11,302,608 shares of Incannex Healthcare common stock at $0 on November 14, 2025 as a restricted stock grant.
Were any indirect IXHL holdings reported?
Yes. Indirect holdings include 242,862 via Alignment Capital Pty Ltd, among other entities.
What plan governed the IXHL equity grant?
The shares were granted under the company’s 2023 Equity Incentive Plan.